oxazolidin-2-one has been researched along with daptomycin in 208 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.48) | 18.2507 |
| 2000's | 66 (31.73) | 29.6817 |
| 2010's | 132 (63.46) | 24.3611 |
| 2020's | 9 (4.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
| Nash, JM | 1 |
| Stephenson, J | 1 |
| Alvarez-Lerma, F; Grau, S; Luis Gimeno, J; Marín, M | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Saxén, H; Vaara, M | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Brown, WJ; Cha, R; Rybak, MJ | 1 |
| Sharpe, JN | 1 |
| Schweiger, ES; Weinberg, JM | 1 |
| Jevitt, LA; McGowan, JE; Raney, PM; Smith, AJ; Tenover, FC; Williams, PP | 1 |
| Eliopoulos, GM | 1 |
| Lerner, DS; Silverberg, NB; Weinberg, JM; Wesson, KM | 1 |
| Naber, KG; Wagenlehner, FM | 1 |
| Johnson, AP; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| LaPlante, KL; Rybak, MJ | 1 |
| Anstead, GM; Owens, AD | 1 |
| Segreti, J | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Booker, BM; Kelchin, P; Ogundele, AB; Smith, PF | 1 |
| Donskey, CJ; Pultz, NJ; Stiefel, U | 1 |
| de Roux, A; Lode, H; Schmidt-Ioanas, M | 1 |
| Ashcraft, D; Pankey, G; Patel, N | 1 |
| Chin, JN; LaPlante, KL; Leuthner, KD; Rybak, MJ | 1 |
| Paterson, DL | 1 |
| Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
| Alder, JD; Anastasiou, DM; Luperchio, SA; Thorne, GM | 1 |
| Khardori, N | 1 |
| Brauers, J; Kresken, M; Menke, A; Morrissey, I; Orland, A; Weiher, H | 1 |
| Abb, J | 1 |
| Alder, JD; Li, T; Mortin, LI; Van Praagh, AD; Zhang, S; Zhang, XX | 1 |
| Chaiban, G; Dvorak, T; Hachem, R; Hanna, H; Jiang, Y; Raad, I; Reitzel, R; Sherertz, R | 1 |
| Bronze, MS; Greenfield, RA; Hoffman-Roberts, HL; Obritsch, MD | 1 |
| Manfredi, R | 1 |
| Chambers, HF; Hegde, SS | 1 |
| Jørgen, B; Melby, KK; Merckoll, P | 1 |
| Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P | 1 |
| Jenkins, I | 1 |
| Martin, CA; Venugopalan, V | 1 |
| Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
| Loffler, CA; Macdougall, C | 1 |
| Ha, NJ; Kim, K; Kim, Y; Lee, DK; Park, KS; Yang, JW | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
| Kollef, MH; Micek, ST; Skrupky, LP | 1 |
| Cosgrove, SE; Fowler, VG | 1 |
| Aksoy, DY; Unal, S | 1 |
| Le Moing, V; Makinson, A | 1 |
| Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Esposito, S; Leone, S; Noviello, S | 1 |
| Backx, M; Healy, B | 1 |
| Decker, CF; Johnson, MD | 1 |
| Lee, C | 1 |
| Bébéar, C; Dauchy, FA; de Barbeyrac, B; Dupon, M; Dutronc, H; Kuli, B; Mégraud, F | 1 |
| Boutoille, D; Corvec, S; Frioux, R; Grossi, O; Raffi, F; Talarmin, JP | 1 |
| Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP | 1 |
| Garcia-Diaz, J; Hasbun, R; Islam, T; Mave, V | 1 |
| Furgeson, SB; Teitelbaum, I | 1 |
| Kaiser, GM; Mathe, Z; Paul, A; Rath, PM; Saner, FH; Treckmann, J; Vernadakis, S | 1 |
| Corey, GR; Stryjewski, ME | 1 |
| LaPlante, KL; Sakoulas, G | 1 |
| Bilal, M; Cleveland, KO; Gelfand, MS | 1 |
| Carson, RT; Friedman, M; Marton, JP; Menzin, J; Meyers, JL; Rothermel, CD | 1 |
| Bonafede, M; Evans, A; Ferro, S; Harrington, S; Lodise, TP; Lubanski, P; Patel, N; Stellrecht, K | 1 |
| Deshpande, LM; Jones, RN; Mendes, RE; Ross, JE; Sader, HS | 1 |
| Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P | 1 |
| Cattoir, V; Daurel, C | 1 |
| Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Appelbaum, PC; Ednie, LM; Lin, G | 1 |
| Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Bocci, G; Ciofi, L; Danesi, R; Del Tacca, M; Di Paolo, A; Lastella, M; Malacarne, P; Menichetti, F; Polillo, M; Tascini, C; Viaggi, B | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
| Concia, E | 1 |
| Buszewski, B; Fuchs, P; Kegler, R; Miekisch, W; Mundkowski, RG; Olszowy, P; Schubert, JK; Szultka, M | 1 |
| Hennenfent, J; Lambert, BL; McBride, MV; Rodvold, KA; Schiff, G; Schumock, GT; Trese, AM; Tverdek, F; Yang, Y | 1 |
| Burillo, A; Gil, Y; Gómez-Garcés, JL; López-Fabal, F | 1 |
| Bandettini, R; Castagnola, E; Caviglia, I; Lorenzi, I; Macrina, G; Tacchella, A | 1 |
| Chen, FJ; Huang, IW; Lauderdale, TL; Lee, CH; Wang, MC | 1 |
| Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
| Arias, CA; Murray, BE; Nannini, E | 1 |
| Casanova-Roman, M; Casas-Ciria, J; Eiros-Bouza, JM; Sanchez-Morenilla, I; Sanchez-Porto, A; Santaella, MJ | 1 |
| Buszewski, B; Fuchs, P; Kegler, R; Miekisch, W; Mundkowski, R; Olszowy, P; Schubert, J; Szultka, M | 1 |
| Barsić, B; Bukovski-Simonoski, S; Pangercić, A | 1 |
| Curcio, D | 1 |
| Daurel, C; Leclercq, R | 1 |
| Ippolito, G; Lauria, FN; Leone, S; Nicastri, E; Wenzel, RP | 1 |
| Dandekar, G; Dandekar, T | 1 |
| Beisser, PS; Croes, S; Deurenberg, RH; Neef, C; Stobberingh, EE; Terporten, PH | 1 |
| Rybak, MJ; Steed, ME; Vidaillac, C | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R | 1 |
| Levy, F; Peterson, SM; Reynolds, SA; Sarubbi, FA; Shams, W; Walker, ES | 1 |
| Baddley, JW; Kunz, DF; McKinnell, JA; Moser, SA; Patel, M; Shirley, RM | 1 |
| Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
| Derendorf, H; Estes, KS | 1 |
| Dryden, M; Eckmann, C | 1 |
| Wilke, MH | 1 |
| Brielmaier, B; Crank, CW; Patel, GP; Ritchie, DJ; Rose, WE; Scheetz, MH; Segreti, J | 1 |
| Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
| Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
| Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
| Adam, HJ; Hoban, DJ; Hussain, Z; Kost, S; Lagacé-Wiens, PR; Mataseje, LF; McCracken, M; Mulvey, MR; Nichol, KA; Thompson, K; Zhanel, GG | 1 |
| Cordero-Ampuero, J; Esteban, J | 1 |
| Cercenado, E | 1 |
| Calabuig, E; Salavert, M | 1 |
| Gould, IM | 1 |
| Chang, SC; Chen, YC; Kao, TM; Wang, JT; Weng, CM | 1 |
| Gray, JW; Patel, M | 1 |
| Downer, C; Grover, C; Heidari, A; Joson, J; Pujar, T | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Chandrasekar, PH; Kosmidis, CI | 1 |
| Gomes, F; Leite, B; Oliveira, R; Pizzolitto, E; Souza, C; Teixeira, P | 1 |
| Bremner, RM; Hodges, TN; Huang, J; Jacobs, JV; Smith, MA; Walia, R | 1 |
| Cleveland, KO; Gelfand, MS; Twilla, JD; Usery, JB | 1 |
| Cleveland, KO; Gelfand, MS; Holloway, K; King, ST; Koeth, L; Usery, JB | 1 |
| Humphries, R; Kelesidis, T; Lewinski, MA; Ward, K; Yang, OO | 1 |
| Cleveland, KO; Memon, KA | 1 |
| Açıkgöz, ZC; Celikbilek, N; Güner, HR; Gürelik, FC; Güvenman, S; Ozdem, B | 1 |
| Sancak, B | 1 |
| Bania, J; Dolna, I; Dworniczek, E; Gościniak, G; Kowalska-Krochmal, B; Seniuk, A; Wałecka, E | 1 |
| Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
| Kelesidis, T | 1 |
| Broyles, JE; Finch, CK; Gelfand, MS; Hudson, JQ; Twilla, JD; Usery, JB | 1 |
| Camou, F | 1 |
| Betriu, C; Canut, A; Gascón, AR; Isla, A | 1 |
| Davis-Boozer, D; Feiz, V; Li, J; Polage, C; Vieira, AC | 1 |
| Buszewski, B; Jackowski, M; Szeliga, J; Szultka, M | 1 |
| Arias, CA; Hall, AD; Murray, BE; Rybak, MJ; Steed, ME | 1 |
| Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
| Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Tsai, HY; Tsao, SM; Wang, LS; Yang, JL; Yu, KW | 1 |
| Chang, CM; Chou, CH; Ko, WC; Lee, CC; Lee, HC; Lee, NY | 1 |
| Bonilla, H; Fakih, MG; Fugelli, A; Johnson, L; Olsen, WM; Pawlak, J; Saravolatz, LD | 1 |
| Niki, Y | 1 |
| Bravo-Molina, A; Hernández-Quero, J; Parra-Ruiz, J; Peña-Monje, A | 1 |
| Ozcimen, M; Sakarya, R; Sakarya, Y | 1 |
| Brink, AJ | 1 |
| Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
| Hellmann, M; Knoll, BM; Kotton, CN | 1 |
| Atalay, S; Ece, G; Köse, I; Köse, S; Maraş, G; Samlıoğlu, P | 1 |
| Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Bathina, P; Bheemreddy, S; Campbell, ML; Chugh, N; Hayakawa, K; Kaye, KS; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Pulluru, H; Rybak, MJ; Sunkara, B; Wilson, MN | 1 |
| Anderson, TA; Kiser, TH; Mueller, SW; Neumann, RT | 1 |
| Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Campanile, F; Comandini, E; Falcone, M; Meledandri, M; Novelli, A; Stefani, S; Vena, A; Venditti, M | 1 |
| Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G; Pareek, S | 1 |
| Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Richards, EP; Sharff, KA; Townes, JM | 1 |
| Flamm, RK; Jones, RN; Sader, HS | 1 |
| Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
| Gardner, J; Toledo-Pereyra, LH; Zaffiri, L | 1 |
| Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA | 1 |
| Abbo, L; Correa, R; Gauthier, TP; Shukla, BS; Smith, L | 1 |
| Bensaid, M; Butin, M; Laurent, F; Picaud, JC; Rasigade, JP | 1 |
| McKinnell, JA; Miller, LG; Partain, NM; Whang, DW | 1 |
| Amoroso, L; Bandettini, R; Banov, L; Barabino, P; Castagnola, E; Ciucci, A; Faraci, M; Loy, A; Moscatelli, A; Risso, F | 1 |
| Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
| Hagioka, S; Hagiya, H; Otsuka, F | 1 |
| Balli, EP; Miyakis, S; Venetis, CA | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Collins, CD; McComb, MN | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Abduljaleel, SA; Atshan, SS; Awang Hamat, R; Ghaznavi-Rad, E; Jeevajothi Nathan, J; Karunanidhi, A; Lung, LT; Mateg Ali, A; Nor Shamsudin, M; Pei Pei, C; Sekawi, Z | 1 |
| Muscedere, J | 1 |
| Anesi, A; Cerri, MC; Maffezzini, E; Minoli, L; Monaco, M; Pantosti, A; Piazza, M; Tinelli, M | 1 |
| Campanile, F; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G; Fossati, L; Motta, I; Ranieri, VM; Stefani, S | 1 |
| Carroll, KC; Dam, LM; Eisinger, SW; Neoh, KM; Riedel, S; Tekle, T | 1 |
| Andreacchio, KA; Cárdenas, AM; Edelstein, PH | 1 |
| Holmberg, A; Rasmussen, M | 1 |
| Arvanitis, M; LaPlante, KL; Luther, MK; Mylonakis, E | 1 |
| Arhin, FF; Moeck, G; Sarmiento, I | 1 |
| Kumar, VA | 1 |
| Bizzini, A; Hartke, A; Rio-Marques, L | 1 |
| Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ | 1 |
| Chitnis, DS; Chitnis, S; Hemavani, N; Katara, G; Pareek, S | 1 |
| Hohenforst-Schmidt, W; Huang, H; Kioumis, I; Lampaki, S; Li, Q; Organtzis, J; Pataka, A; Petridis, D; Pezirkianidis, N; Pitsiou, G; Porpodis, K; Spyratos, D; Yarmus, L; Zarogoulidis, K; Zarogoulidis, P | 1 |
| Cleveland, KO; Finch, CK; Gelfand, MS; Self, TH; Usery, JB; Vo, NH | 1 |
| Arnold, C; Fowler, VG; Holland, TL | 1 |
| Coato, P; Cojutti, P; Pea, F; Rigoli, R; Sartor, A; Scarparo, C | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Gallagher, JC; Patel, R | 1 |
| Chang, SC; Chuang, YC; Lin, HY; Wang, JT | 1 |
| Mischnik, A; Mutters, NT; Tacconelli, E; Werner, G | 1 |
| Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Hoeft, A; Jahnert, S; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C | 1 |
| Bodmann, KF; Mutters, R | 1 |
| Mischnik, A; Mutters, NT | 1 |
| Cardona, AF; Wilson, SE | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
| Kebriaei, R; Rice, S; Rybak, MJ; Smith, JR; Stamper, K; Yim, J | 1 |
| Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
| Avaca-Crusca, JS; Camargo, ILBDC; Dabul, ANG; Okado, JB; Oliveira, AL | 1 |
| Arias, CA; Murray, BE; Singh, KV | 2 |
| Bender, J; Mischnik, A; Mutters, NT; Werner, G | 1 |
| Kalantzi, S; Konsta, E; Loupa, CV; Lykoudi, E; Meimeti, E; Moisoglou, I; Voyatzoglou, ED | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
| Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
| Aspinall, SL; Buehrle, DJ; Clancy, CJ; Smith, KJ; Vu, M | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Carvalhaes, CG; Castanheira, M; DeVries, S; Mendes, RE; Rhomberg, PR; Sader, HS | 1 |
| Ito, Y; Kanda, N; Kano, Y; Kobuchi, S; Okumi, T; Sakaeda, T; Tachi, H | 1 |
58 review(s) available for oxazolidin-2-one and daptomycin
| Article | Year |
|---|---|
[Problems and current solutions for the treatment of infections caused by gram-positive microorganisms].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance; Gram-Positive Bacterial Infections; Humans; Macrolides; Oxazolidinones; Streptogramins | 2001 |
[New antibacterial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin | 1999 |
Novel antibacterial agents for skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin | 2004 |
Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Oxazolidinones; Skin Diseases, Bacterial; Virginiamycin | 2004 |
New drugs for Gram-positive uropathogens.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Urinary Tract Infections; Urine | 2004 |
Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin | 2004 |
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Critical Illness; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin | 2005 |
Clinical experience with recently approved antibiotics.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Infections; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Staphylococcal Infections; Streptococcal Infections; Tigecycline; Virginiamycin | 2006 |
In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Virginiamycin | 2006 |
Antibiotics--past, present, and future.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactams; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Drug Therapy; Fluoroquinolones; Glycopeptides; Humans; Macrolides; Oxazolidinones; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance, Microbial; Glycopeptides; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptides, Cyclic; Vancomycin | 2007 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapy.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Diseases, Infectious; Daptomycin; Humans; Linezolid; Minocycline; Osteomyelitis; Oxazolidinones; Tigecycline | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Daptomycin; Endocarditis; Equipment Contamination; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2007 |
New antimicrobial agents for the treatment of Gram-positive bacterial infections.
Topics: Acetamides; Anti-Infective Agents; Cephalosporins; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
[New anti-Gram+antibiotics: which role in infective endocarditis?].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Endocarditis; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
[Skin and soft tissue infections: current therapeutic options].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome | 2008 |
Serious staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin Resistance | 2008 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Therapeutic challenges in the era of antibiotic resistance.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline | 2008 |
New treatments for methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Daptomycin; Evidence-Based Medicine; Glycopeptides; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pyrimidines; Streptococcal Infections; Tigecycline | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
[Therapy of SSTI and role of tigecycline].
Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection | 2009 |
Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections | 2010 |
[Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome | 2010 |
Methicillin-resistant Staphylococcus aureus: the superbug.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Treatment Outcome | 2010 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
Multiresistant bacteria and current therapy - the economical side of the story.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple; Economics, Pharmaceutical; Linezolid; Minocycline; Oxazolidinones; Tigecycline | 2010 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
Treatment of prosthetic osteoarticular infections.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Consensus; Daptomycin; Drug Resistance, Multiple; Humans; Interdisciplinary Communication; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Prosthesis-Related Infections; Reoperation | 2011 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Management of antibiotic-resistant infection in the newborn.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Management of gram-positive bacterial infections in patients with cancer.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Minocycline; Neoplasms; Oxazolidinones; Tigecycline | 2012 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycoproteins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Vancomycin Resistance | 2012 |
New antibiotic agents: problems and prospects.
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pseudomonas aeruginosa; Surgical Wound Infection; Tigecycline; Vancomycin Resistance | 2005 |
Clinical management of septic arthritis.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Immunologic Factors; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Staphylococcal Infections; Treatment Outcome; Virginiamycin | 2013 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance | 2013 |
Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.
Topics: Acetamides; Bacteremia; Daptomycin; Enterococcus; Humans; Linezolid; Oxazolidinones; Vancomycin Resistance | 2013 |
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Combinations; Enterococcus; Humans; Linezolid; Middle Aged; Oxazolidinones; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Clinical management of Staphylococcus aureus bacteremia: a review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2014 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Linezolid; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
[Treatment options for serious infections caused by vancomycin-resistant enterococci].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterobacteriaceae; Evidence-Based Medicine; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin-Resistant Enterococci | 2015 |
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Daptomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections | 2015 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
[Enterococci With Special Resistance Patterns - Epidemiology, Hygiene and Therapy].
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Oxazolidinones; Tetrazoles; Tigecycline; Vancomycin Resistance | 2019 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
150 other study(ies) available for oxazolidin-2-one and daptomycin
| Article | Year |
|---|---|
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin | 2000 |
The antibiotics crisis. We're in the midst of an escalating arms race with the microbe, and we may be losing.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Design; Drug Resistance, Microbial; Health Services Misuse; Humans; Linezolid; Oxazolidinones; Patient Compliance; Pharmacogenetics; United States | 2001 |
Researchers describe latest strategies to combat antibiotic-resistant microbes.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Daptomycin; Drug Industry; Drug Resistance, Microbial; Drugs, Investigational; Europe; Humans; Linezolid; Oxazolidinones; Protein Synthesis Inhibitors | 2001 |
In vitro bactericidal activity of daptomycin against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2002 |
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin | 2003 |
Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Culture Media; Daptomycin; Drug Therapy, Combination; Endocardium; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Virginiamycin | 2003 |
Antibiotics as an adjunct to surgical management of lower extremity ulcerations.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Debridement; Diabetic Foot; Drug Resistance, Microbial; Female; Foot Ulcer; Glycopeptides; Humans; Leg Ulcer; Linezolid; Lipoglycopeptides; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Wound Healing | 2004 |
In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Genes, Bacterial; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin Resistance; Virginiamycin | 2003 |
Current and new antimicrobial agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Virginiamycin | 2004 |
Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus | 2004 |
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Culture Media; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Half-Life; Kinetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillins; Staphylococcus aureus; Vancomycin | 2004 |
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones | 2005 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Linezolid; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Virginiamycin | 2005 |
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; Daptomycin; Enterococcus; Female; Humans; Intestines; Klebsiella pneumoniae; Linezolid; Mice; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2005 |
In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin Resistance | 2005 |
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2006 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2007 |
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Female; Linezolid; Luminescent Measurements; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Peritonitis; Staphylococcus aureus | 2007 |
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2007 |
Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Norway; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Virginiamycin | 2007 |
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus aureus; Thienopyridines; Thiophenes; Virginiamycin | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Korea; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Tigecycline; Vancomycin Resistance; Virginiamycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Bone and Bones; Daptomycin; Drug Synergism; Humans; Joints; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Tigecycline | 2009 |
[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Topics: Acetamides; Aged, 80 and over; Anesthesia; Anti-Bacterial Agents; Bacteremia; Bone Marrow Diseases; Comorbidity; Contraindications; Daptomycin; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Hip Prosthesis; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 2009 |
Drugs for MRSA with reduced susceptibility to vancomycin.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin Resistance | 2009 |
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin Resistance; Young Adult | 2009 |
New treatment options and protocols for peritoneal dialysis-related peritonitis.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Virginiamycin | 2009 |
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cross Infection; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Daptomycin; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Utilization; Drug Utilization Review; Female; Humans; Inpatients; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2009 |
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; RNA, Bacterial; RNA, Ribosomal, 23S; Staphylococcus | 2009 |
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin | 2010 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sisomicin; Time Factors | 2010 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma.
Topics: Acetamides; Adult; Aged; Chromatography, High Pressure Liquid; Daptomycin; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Technology, Pharmaceutical | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.
Topics: Acetamides; Anti-Bacterial Agents; Anticoagulants; Aza Compounds; Chromatography, High Pressure Liquid; Daptomycin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Linezolid; Moxifloxacin; Oxazolidinones; Polymers; Pyrroles; Quinolines; Salts; Solid Phase Microextraction | 2010 |
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Protocols; Daptomycin; Formularies, Hospital as Topic; Guidelines as Topic; Health Care Surveys; Hospitals; Humans; Infection Control; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Organizational Policy; Oxazolidinones; Patient Isolation; Pharmacy Service, Hospital; Staphylococcal Infections; Surveys and Questionnaires; Tigecycline; Vancomycin | 2010 |
[Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2010 |
Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Chi-Square Distribution; Child; Coagulase; Daptomycin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Prospective Studies; Staphylococcus; Vancomycin | 2010 |
Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cell Membrane; Colony Count, Microbial; Daptomycin; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Humans; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Reagent Strips; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin Resistance | 2010 |
New coated SPME fibers for extraction and fast HPLC determination of selected drugs in human blood.
Topics: Acetamides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Humans; Linezolid; Oxazolidinones; Polymers; Pyrroles; Solid Phase Microextraction; Thiophenes | 2010 |
[Vancomycin, what else?].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Child; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovative.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Computational Biology; Daptomycin; Drug Delivery Systems; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Forecasting; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Minocycline; Oxazolidinones; Pharmacogenetics; Systems Biology; Tigecycline; Virginiamycin | 2010 |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Penicillin Resistance; Penicillin-Binding Proteins; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
Topics: Acetamides; Anti-Infective Agents; Cefepime; Cephalosporins; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Vancomycin | 2010 |
Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; Daptomycin; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
Topics: Acetamides; Aged; Anti-Infective Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin Resistance | 2011 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Data Interpretation, Statistical; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Multivariate Analysis; Oxazolidinones; Prognosis; Retrospective Studies; Treatment Outcome; Vancomycin Resistance | 2010 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Canada; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Exotoxins; Female; Hospitals; Humans; Infant; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin Resistance | 2011 |
[Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Daptomycin; Databases, Factual; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Kidney Diseases; Linezolid; Microbial Sensitivity Tests; Minocycline; Multicenter Studies as Topic; Neutropenia; Oxazolidinones; Registries; Retrospective Studies; Risk Factors; Tigecycline; Treatment Outcome | 2010 |
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Taiwan; Tigecycline; Vancomycin | 2011 |
Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Linezolid; Lipoglycopeptides; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mitral Valve; Oxazolidinones; Paraparesis; Staphylococcal Infections; Treatment Failure | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms.
Topics: Acetamides; Biofilms; Colony Count, Microbial; Daptomycin; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2011 |
Hardware preservation after sternal wound infection in a lung transplant recipient.
Topics: Acetamides; Anti-Bacterial Agents; Bone Plates; Bone Screws; Daptomycin; Debridement; Humans; Idiopathic Pulmonary Fibrosis; Infusions, Intravenous; Linezolid; Lung Transplantation; Male; Middle Aged; Negative-Pressure Wound Therapy; Oxazolidinones; Postoperative Care; Staphylococcal Infections; Sternotomy; Surgical Wound Infection; Wound Closure Techniques | 2011 |
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2011 |
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Humans; Linezolid; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Treatment Outcome | 2011 |
Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Oxazolidinones; Staphylococcal Infections | 2011 |
[In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2011 |
Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland.
Topics: Acetamides; Agar; Anti-Bacterial Agents; Biofilms; Daptomycin; Deoxyribonucleases; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Gelatinases; Glycopeptides; Hemolysin Proteins; Hospitalization; Humans; Linezolid; Lipase; Minocycline; Norfloxacin; Oxazolidinones; Phenotype; Poland; Tigecycline; Virulence | 2011 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Vancomycin | 2012 |
Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Enterococcus faecalis; Female; Humans; Immunocompromised Host; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Retrospective Studies; United States; Vancomycin; Vancomycin Resistance | 2012 |
Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Oxazolidinones; Staphylococcal Infections | 2012 |
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
Topics: Acetamides; Anti-Bacterial Agents; Belgium; Daptomycin; Ireland; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Staphylococcal Infections; Tigecycline; United Kingdom; Vancomycin | 2012 |
The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Daptomycin; Dextrans; Drug Stability; Drug Therapy, Combination; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Oxazolidinones; Pilot Projects; Staphylococcal Infections; Treatment Outcome | 2012 |
Development of novel molecularly imprinted solid-phase microextraction fibers and their application for the determination of antibiotic drugs in biological samples by SPME-LC/MS(n).
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Daptomycin; Humans; Linezolid; Mass Spectrometry; Molecular Imprinting; Oxazolidinones; Polymers; Pyrroles; Sensitivity and Specificity; Solid Phase Microextraction; Thiophenes | 2012 |
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Acetamides; Daptomycin; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Oxazolidinones; Taiwan; Tigecycline; Vancomycin Resistance | 2012 |
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Topics: Acetamides; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Incidence; Linezolid; Male; Middle Aged; Oxazolidinones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligopeptides; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2012 |
Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Daptomycin; Drug Interactions; Humans; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections | 2012 |
The safety and efficacy of linezolid and daptomycin as an additive in optisol-GS against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Chondroitin Sulfates; Daptomycin; Dextrans; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Organ Preservation Solutions; Oxazolidinones | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin Resistance; Virginiamycin | 2013 |
[Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Culture Media; Daptomycin; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Turkey; Vancomycin Resistance; Young Adult | 2012 |
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin | 2013 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Topics: Acetamides; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cohort Studies; Cost Savings; Daptomycin; Drug Costs; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Retrospective Studies; Severity of Illness Index; Staphylococcal Infections; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Topics: Acetamides; Administration, Intravenous; Anti-Bacterial Agents; Cerebral Ventriculitis; Daptomycin; Dose-Response Relationship, Drug; Drainage; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance | 2012 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Blood-Brain Barrier; Daptomycin; Female; Glycopeptides; Humans; Linezolid; Meningitis; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Staphylococcus epidermidis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.
Topics: Acetamides; Daptomycin; Enterococcus; Humans; In Vitro Techniques; India; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
Topics: Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; History, 20th Century; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin | 2013 |
Effect of pulmonary surfactant on antimicrobial activity in vitro.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline | 2013 |
[Management of late-onset sepsis due to coagulase-negative staphylococci in neonatal intensive care units].
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Oxazolidinones; Sepsis; Staphylococcal Infections; Vancomycin Resistance | 2013 |
Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.
Topics: Acetamides; Anti-Bacterial Agents; Child; Coagulase; Daptomycin; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Structure-Activity Relationship; Vancomycin | 2014 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Fatal Outcome; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pulmonary Embolism; Staphylococcal Infections; Treatment Failure; Vancomycin | 2013 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Decision Support Techniques; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Models, Economic; Monte Carlo Method; Oxazolidinones; Quality-Adjusted Life Years; Vancomycin | 2014 |
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Daptomycin; Genetic Variation; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Staphylococcus aureus toxic shock syndrome toxin-1 endocarditis with muscular metastatic abscesses.
Topics: Abscess; Acetamides; Adult; Anti-Bacterial Agents; Bacterial Toxins; Daptomycin; Endocarditis, Bacterial; Enterotoxins; Female; Humans; Linezolid; Muscular Diseases; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Superantigens | 2014 |
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Genotyping Techniques; Humans; Intensive Care Units; Italy; Linezolid; Methicillin-Resistant Staphylococcus aureus; Molecular Epidemiology; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2014 |
Prevalence and detection of mixed-population enterococcal bacteremia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Coinfection; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multilocus Sequence Typing; Oxazolidinones; Prevalence; Treatment Outcome; Vancomycin Resistance | 2014 |
Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Bone Cements; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Rifampin; Tigecycline | 2014 |
Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Gal
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Daptomycin; Drug Interactions; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Larva; Linezolid; Microbial Sensitivity Tests; Models, Biological; Models, Statistical; Moths; Oxazolidinones; Rifampin | 2014 |
In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Gene Expression; Glycopeptides; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Vancomycin | 2014 |
Susceptibility testing of Staphylococaus aureus.
Topics: Acetamides; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin Resistance | 2014 |
The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin | 2014 |
Authors' response.
Topics: Acetamides; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin Resistance | 2014 |
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.
Topics: Acetamides; Aerosols; Anti-Bacterial Agents; Daptomycin; Equipment Design; Linezolid; Nebulizers and Vaporizers; Oxazolidinones; Particle Size; Vancomycin | 2014 |
Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Health Care Costs; Hospitalization; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Tennessee; Treatment Outcome; Vancomycin | 2015 |
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Topics: Acetamides; Anti-Bacterial Agents; Blood; Daptomycin; Health Surveys; Humans; Italy; Linezolid; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2015 |
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.
Topics: Acetamides; Anti-Bacterial Agents; Cell Line; Cytokines; Daptomycin; Escherichia coli; Gene Expression Profiling; Gram-Positive Bacteria; Humans; Immunologic Factors; Linezolid; Models, Theoretical; Monocytes; Oxazolidinones; Phagocytosis; Sepsis; Toll-Like Receptors; Vancomycin | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecyclin?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecycline?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an
Topics: Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Tetrazoles | 2018 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Topics: Bacterial Proteins; Bacteriolysis; Brazil; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Polymorphism, Single Nucleotide; Staphylococcal Infections; Tetrazoles; Vancomycin | 2018 |
Efficacy of Tedizolid against Enterococci and Staphylococci, Including
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Disease Models, Animal; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcus; Tetrazoles | 2019 |
Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Staphylococcal Infections; Tetrazoles; Vancomycin Resistance; Vancomycin-Resistant Staphylococcus aureus | 2020 |
Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin.
Topics: Anti-Bacterial Agents; Burns; Daptomycin; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Teicoplanin; Tetrazoles; Tigecycline | 2020 |
High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Daptomycin; Humans; Linezolid; Oxazolidinones; Reproducibility of Results; Tandem Mass Spectrometry; Tetrazoles | 2021 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Vancomycin | 2021 |
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Hospitals; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Tetrazoles; United States; Vancomycin | 2022 |
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Sepsis; Tissue Distribution; Vancomycin | 2022 |